Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Class A Common Stock
-
Shares outstanding
-
112M
-
Number of holders
-
226
-
Total 13F shares, excl. options
-
95.5M
-
Shares change
-
+6.95M
-
Total reported value, excl. options
-
$2.68B
-
Value change
-
+$173M
-
Put/Call ratio
-
0.49
-
Number of buys
-
117
-
Number of sells
-
-127
-
Price
-
$28.08
Significant Holders of Evolent Health, Inc. - Class A Common Stock (EVH) as of Q4 2022
294 filings reported holding EVH - Evolent Health, Inc. - Class A Common Stock as of Q4 2022.
Evolent Health, Inc. - Class A Common Stock (EVH) has 226 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 95.5M shares
of 112M outstanding shares and own 85.54% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (9.79M shares), BlackRock Inc. (7.7M shares), FMR LLC (4.66M shares), Rock Springs Capital Management LP (3.8M shares), Point72 Asset Management, L.P. (3.27M shares), Granahan Investment Management, LLC (3.18M shares), Invesco Ltd. (2.9M shares), ORBIMED ADVISORS LLC (2.82M shares), Engaged Capital LLC (2.79M shares), and CITADEL ADVISORS LLC (2.6M shares).
This table shows the top 226 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.